Author

R. Lordan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Mrcela· 1 shared E. Ricciotti· 1 shared G. A. FitzGerald· 1 shared G. R. Grant· 1 shared J. Aoyama· 1 shared J. Yang· 1 shared R. Joshi· 1 shared R. McConnell· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Mrcela

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Disruption of the PGE2 synthesis / response pathway restrains atherogenesis in programmed cell death-1 (Pd-1) deficient hyperlipidemic mice

E. Ricciotti, S. Y. Tang, A. Mrcela, U. Das, R. Lordan, R. Joshi, S. Ghosh, J. Aoyama, R. McConnell, J. Yang, G. R. Grant, G. A. FitzGerald

This study shows that disrupting the PGE2 synthesis or response pathway reduces atherogenesis in PD-1 deficient hyperlipidemic mice through different immune mechanisms.

bioRxiv · Jul 2, 2024 · PreprintPharmacology & Toxicology